Hepatitis B and hepatitis C in 2009
- 21 January 2009
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 29 (s1) , 1-8
- https://doi.org/10.1111/j.1478-3231.2008.01947.x
Abstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the most frequent viral infections in humans, and represent a major global public health problem. HBV- and HCV-related chronic hepatitis are the main causes of cirrhosis and hepatocellular carcinoma (HCC) that are responsible for a high rate of morbidity and mortality. End-stage HBV- and HCV-related liver disease and HCC are the main causes of liver transplantation. In the last few years, knowledge of the epidemiology and the natural history of HBV and HCV infection has markedly improved. Furthermore, considerable progress has been made in the efficacy of therapy. New drugs and new therapeutic strategies that are currently under evaluation could further improve the efficacy of therapy in the near future.Keywords
This publication has 75 references indexed in Scilit:
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients #Hepatology, 2009
- Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis CHepatology, 2007
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative casesJournal of Hepatology, 2006
- Resistance to adefovir: A new challenge in the treatment of chronic hepatitis BJournal of Hepatology, 2005
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- Natural History and Prognosis of Hepatitis BSeminars in Liver Disease, 2003
- EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS BJournal of Hepatology, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999